ADA Professional Publications
@adapubs.bsky.social
ADA’s Professional Publications—Diabetes, Diabetes Care, Clinical Diabetes, Diabetes Spectrum, Diabetes, Obesity & Cardiometabolic Care, and books—are leading sources on diabetes research, care, prevention & treatment. @amdiabetesassn.bsky.social
Pinned
🚨 NEW special #podcast
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function
Read more ➡️ doi.org/10.2337/db25-0475
Read more ➡️ doi.org/10.2337/db25-0475
November 11, 2025 at 6:00 PM
Deleterious Effects of a GAD65 Monoclonal Autoantibody on Islet Function
Read more ➡️ doi.org/10.2337/db25-0475
Read more ➡️ doi.org/10.2337/db25-0475
Meta-analysis showed multi-modal interventions using non-surgical approaches can safely increase T2D remission rates & improve A1C & quality of life. Tailored approaches are key. #T2DRemission
Read more ➡️ doi.org/10.2337/dc25-0562
Read more ➡️ doi.org/10.2337/dc25-0562
November 11, 2025 at 2:25 PM
Meta-analysis showed multi-modal interventions using non-surgical approaches can safely increase T2D remission rates & improve A1C & quality of life. Tailored approaches are key. #T2DRemission
Read more ➡️ doi.org/10.2337/dc25-0562
Read more ➡️ doi.org/10.2337/dc25-0562
🚨 NEW special #podcast
In this special episode of DCU's ongoing "What's Next" series, Neil Skolnik covers the latest updates on beta cell function and its role in the early detection of #T1D.
👂 Listen now at: diabetesjournals.org/journals/pag...
This episode is sponsored by Sanofi.
In this special episode of DCU's ongoing "What's Next" series, Neil Skolnik covers the latest updates on beta cell function and its role in the early detection of #T1D.
👂 Listen now at: diabetesjournals.org/journals/pag...
This episode is sponsored by Sanofi.
November 10, 2025 at 9:15 PM
🚨 NEW special #podcast
In this special episode of DCU's ongoing "What's Next" series, Neil Skolnik covers the latest updates on beta cell function and its role in the early detection of #T1D.
👂 Listen now at: diabetesjournals.org/journals/pag...
This episode is sponsored by Sanofi.
In this special episode of DCU's ongoing "What's Next" series, Neil Skolnik covers the latest updates on beta cell function and its role in the early detection of #T1D.
👂 Listen now at: diabetesjournals.org/journals/pag...
This episode is sponsored by Sanofi.
🚨 New for November, a fresh episode of the #DiabetesBio #podcast!
Featuring:
✨ Diabetes genetic clusters
✨ Weight loss with LEAP2 & Semaglutide
✨ Plus! Sweet Talk w Jens Juul Holst
🎙️Listen at: http://diabetesbio.libsyn.com
📚Read more: http://diabetesjournals.org/diabetes/issue/74/11
Featuring:
✨ Diabetes genetic clusters
✨ Weight loss with LEAP2 & Semaglutide
✨ Plus! Sweet Talk w Jens Juul Holst
🎙️Listen at: http://diabetesbio.libsyn.com
📚Read more: http://diabetesjournals.org/diabetes/issue/74/11
November 7, 2025 at 6:57 PM
🚨 New for November, a fresh episode of the #DiabetesBio #podcast!
Featuring:
✨ Diabetes genetic clusters
✨ Weight loss with LEAP2 & Semaglutide
✨ Plus! Sweet Talk w Jens Juul Holst
🎙️Listen at: http://diabetesbio.libsyn.com
📚Read more: http://diabetesjournals.org/diabetes/issue/74/11
Featuring:
✨ Diabetes genetic clusters
✨ Weight loss with LEAP2 & Semaglutide
✨ Plus! Sweet Talk w Jens Juul Holst
🎙️Listen at: http://diabetesbio.libsyn.com
📚Read more: http://diabetesjournals.org/diabetes/issue/74/11
Genome-Wide Association Study of Hypoglycemia in Adults With Diabetes in the Million Veteran Program
Read more ➡️ doi.org/10.2337/db25-0304
Read more ➡️ doi.org/10.2337/db25-0304
November 7, 2025 at 6:01 PM
Genome-Wide Association Study of Hypoglycemia in Adults With Diabetes in the Million Veteran Program
Read more ➡️ doi.org/10.2337/db25-0304
Read more ➡️ doi.org/10.2337/db25-0304
🚨 A new Care on Air! Where #podcast hosts Mike and Alice discuss the latest and greatest of Diabetes Care.
🎧 diabetescareonair.libsyn.com/site
In this ep:
✨ Undiagnosed G6PD deficiencies w @InesBarroso4
✨ Upper-limb complications
✨ and more!
Read the full issue ➡️
http://diabetesjournals.org/care
🎧 diabetescareonair.libsyn.com/site
In this ep:
✨ Undiagnosed G6PD deficiencies w @InesBarroso4
✨ Upper-limb complications
✨ and more!
Read the full issue ➡️
http://diabetesjournals.org/care
November 6, 2025 at 6:37 PM
🚨 A new Care on Air! Where #podcast hosts Mike and Alice discuss the latest and greatest of Diabetes Care.
🎧 diabetescareonair.libsyn.com/site
In this ep:
✨ Undiagnosed G6PD deficiencies w @InesBarroso4
✨ Upper-limb complications
✨ and more!
Read the full issue ➡️
http://diabetesjournals.org/care
🎧 diabetescareonair.libsyn.com/site
In this ep:
✨ Undiagnosed G6PD deficiencies w @InesBarroso4
✨ Upper-limb complications
✨ and more!
Read the full issue ➡️
http://diabetesjournals.org/care
GLP-1RA and DPP4i do not increase pancreatitis risk vs. SGLT2i, but both are linked to a small rise in biliary disease risk in real-world data from >1 million patients with type 2 diabetes.
Read more ➡️ doi.org/10.2337/dc25-1260
Read more ➡️ doi.org/10.2337/dc25-1260
November 6, 2025 at 6:00 PM
GLP-1RA and DPP4i do not increase pancreatitis risk vs. SGLT2i, but both are linked to a small rise in biliary disease risk in real-world data from >1 million patients with type 2 diabetes.
Read more ➡️ doi.org/10.2337/dc25-1260
Read more ➡️ doi.org/10.2337/dc25-1260
Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes
Read more ➡️ doi.org/10.2337/db25-0354
Read more ➡️ doi.org/10.2337/db25-0354
November 5, 2025 at 6:00 PM
Multiomics Integration of Epigenetics, Proteomics, and Metabolomics Identifies Putative Drug Targets and Improves Early Prediction for Diabetes
Read more ➡️ doi.org/10.2337/db25-0354
Read more ➡️ doi.org/10.2337/db25-0354
Post-hoc analysis of SYNERGY-NASH: weight, HbA1c & liver fat reductions were associated with MASH & fibrosis improvement, suggesting they may drive histologic response with tirzepatide in MASH.
Read more ➡️ doi.org/10.2337/dc25-1306
Read more ➡️ doi.org/10.2337/dc25-1306
November 4, 2025 at 6:00 PM
Post-hoc analysis of SYNERGY-NASH: weight, HbA1c & liver fat reductions were associated with MASH & fibrosis improvement, suggesting they may drive histologic response with tirzepatide in MASH.
Read more ➡️ doi.org/10.2337/dc25-1306
Read more ➡️ doi.org/10.2337/dc25-1306
🚨 For November, we've got a brand new ep of #DiabetesCoreUpdate, the #podcast that covers the most important articles in the field of #diabetes.
🎧Listen at: bit.ly/DOC_Update
This month:
✨Dementia risk & T1D
✨FLOW Trial: Effects of Semaglutide use in those with T2D & kidney disease
✨and more!
🎧Listen at: bit.ly/DOC_Update
This month:
✨Dementia risk & T1D
✨FLOW Trial: Effects of Semaglutide use in those with T2D & kidney disease
✨and more!
November 4, 2025 at 3:40 PM
🚨 For November, we've got a brand new ep of #DiabetesCoreUpdate, the #podcast that covers the most important articles in the field of #diabetes.
🎧Listen at: bit.ly/DOC_Update
This month:
✨Dementia risk & T1D
✨FLOW Trial: Effects of Semaglutide use in those with T2D & kidney disease
✨and more!
🎧Listen at: bit.ly/DOC_Update
This month:
✨Dementia risk & T1D
✨FLOW Trial: Effects of Semaglutide use in those with T2D & kidney disease
✨and more!
δ-Cells Control a Subset of β-Cells in Mouse Pancreatic Islets
Read more ➡️ doi.org/10.2337/db25-0302
Read more ➡️ doi.org/10.2337/db25-0302
November 3, 2025 at 6:00 PM
δ-Cells Control a Subset of β-Cells in Mouse Pancreatic Islets
Read more ➡️ doi.org/10.2337/db25-0302
Read more ➡️ doi.org/10.2337/db25-0302
Combined Weight Loss and Exercise Training Alters Skeletal Muscle Subcellular Lipid Localization and Intermuscular Adipose Tissue Cellular Composition
Read more ➡️ doi.org/10.2337/db25-0492
Read more ➡️ doi.org/10.2337/db25-0492
October 31, 2025 at 5:00 PM
Combined Weight Loss and Exercise Training Alters Skeletal Muscle Subcellular Lipid Localization and Intermuscular Adipose Tissue Cellular Composition
Read more ➡️ doi.org/10.2337/db25-0492
Read more ➡️ doi.org/10.2337/db25-0492
At T1D diagnosis, Swedish children lacking autoantibodies were more likely to be male, had parental T2D, a higher HbA1c, and less likely to present with DKA, compared to children with autoantibodies.
Read more ➡️ doi.org/10.2337/dc25-0840
Read more ➡️ doi.org/10.2337/dc25-0840
October 30, 2025 at 5:00 PM
At T1D diagnosis, Swedish children lacking autoantibodies were more likely to be male, had parental T2D, a higher HbA1c, and less likely to present with DKA, compared to children with autoantibodies.
Read more ➡️ doi.org/10.2337/dc25-0840
Read more ➡️ doi.org/10.2337/dc25-0840
Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells
Read more ➡️ doi.org/10.2337/db24-0527
Read more ➡️ doi.org/10.2337/db24-0527
October 29, 2025 at 5:00 PM
Proteogenomic Discovery of Novel Open Reading Frames With HLA Immune Presentation on Human β-Cells
Read more ➡️ doi.org/10.2337/db24-0527
Read more ➡️ doi.org/10.2337/db24-0527
For type 2 diabetes-complicated pregnancies, overly stringent weight control should be treated with caution if optimal glycemic control has not been achieved.
Read more ➡️ doi.org/10.2337/dc25-1086
Read more ➡️ doi.org/10.2337/dc25-1086
October 28, 2025 at 5:02 PM
For type 2 diabetes-complicated pregnancies, overly stringent weight control should be treated with caution if optimal glycemic control has not been achieved.
Read more ➡️ doi.org/10.2337/dc25-1086
Read more ➡️ doi.org/10.2337/dc25-1086
Nearly 100 million US adults have prediabetes. "Understanding and Interrupting Progressive Dysglycemia and Associated Complications” explores root causes and solutions.
Read ➡️ doi.org/10.2337/dbi25-0006
#prediabetes #type2diabetes #cardiovasculardisease
Read ➡️ doi.org/10.2337/dbi25-0006
#prediabetes #type2diabetes #cardiovasculardisease
October 27, 2025 at 5:01 PM
Nearly 100 million US adults have prediabetes. "Understanding and Interrupting Progressive Dysglycemia and Associated Complications” explores root causes and solutions.
Read ➡️ doi.org/10.2337/dbi25-0006
#prediabetes #type2diabetes #cardiovasculardisease
Read ➡️ doi.org/10.2337/dbi25-0006
#prediabetes #type2diabetes #cardiovasculardisease
Community paramedics can deliver DSMES at home to high-risk adults with diabetes, improving HbA1c, care engagement, and self-management in rural and underserved settings.
Read more ➡️ doi.org/10.2337/dc25-1580
@ADA_Pubs
Read more ➡️ doi.org/10.2337/dc25-1580
@ADA_Pubs
October 24, 2025 at 5:01 PM
Community paramedics can deliver DSMES at home to high-risk adults with diabetes, improving HbA1c, care engagement, and self-management in rural and underserved settings.
Read more ➡️ doi.org/10.2337/dc25-1580
@ADA_Pubs
Read more ➡️ doi.org/10.2337/dc25-1580
@ADA_Pubs
October 23, 2025 at 5:00 PM
Automated insulin delivery (AID) systems benefit adults with type 2 diabetes regardless of C-peptide level, challenging current CMS coverage criteria and supporting broader access to AID technology.
Read here ➡️ doi.org/10.2337/dc25-1125
Read here ➡️ doi.org/10.2337/dc25-1125
October 22, 2025 at 5:06 PM
Automated insulin delivery (AID) systems benefit adults with type 2 diabetes regardless of C-peptide level, challenging current CMS coverage criteria and supporting broader access to AID technology.
Read here ➡️ doi.org/10.2337/dc25-1125
Read here ➡️ doi.org/10.2337/dc25-1125
🚨 NEW special #podcast
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
October 21, 2025 at 5:19 PM
🚨 NEW special #podcast
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
In the first episode of a new series on the Cardiovascular Outcome Trials
we speak w Steven Nissen, MD, to place the landmark trials into a historical context.
👂Listen now at: diabetesjournals.org/journals/pages/podcasts_cvot
Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1
Read here ➡️ doi.org/10.2337/db25-0207
@ADA_Pubs
Read here ➡️ doi.org/10.2337/db25-0207
@ADA_Pubs
October 21, 2025 at 5:05 PM
Novel Function of Osteoprotegerin in the Modulation of Glucose Metabolism in the Liver via mTORC1
Read here ➡️ doi.org/10.2337/db25-0207
@ADA_Pubs
Read here ➡️ doi.org/10.2337/db25-0207
@ADA_Pubs
⭐ 📖 Paper of the Month: Nov
Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice
-Holm et al.
➡️ doi.org/10.2337/db24-1056
Articles are chosen 🗓️ monthly & 🆓 to read online #paperofthemonth #diabetes
Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice
-Holm et al.
➡️ doi.org/10.2337/db24-1056
Articles are chosen 🗓️ monthly & 🆓 to read online #paperofthemonth #diabetes
October 21, 2025 at 5:00 PM
⭐ 📖 Paper of the Month: Nov
Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice
-Holm et al.
➡️ doi.org/10.2337/db24-1056
Articles are chosen 🗓️ monthly & 🆓 to read online #paperofthemonth #diabetes
Sustained Weight Loss With Combined LEAP2 and Semaglutide Treatment in Mice
-Holm et al.
➡️ doi.org/10.2337/db24-1056
Articles are chosen 🗓️ monthly & 🆓 to read online #paperofthemonth #diabetes
👀 The November 2025 issue of Diabetes Care is here, with the latest research on #diabetes management & care.
🔗http://diabetesjournals.org/care/issue/48/11
Featuring:
✨ Dementia risk & T1D
✨ The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
✨ & more!
🔗http://diabetesjournals.org/care/issue/48/11
Featuring:
✨ Dementia risk & T1D
✨ The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
✨ & more!
October 20, 2025 at 7:15 PM
👀 The November 2025 issue of Diabetes Care is here, with the latest research on #diabetes management & care.
🔗http://diabetesjournals.org/care/issue/48/11
Featuring:
✨ Dementia risk & T1D
✨ The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
✨ & more!
🔗http://diabetesjournals.org/care/issue/48/11
Featuring:
✨ Dementia risk & T1D
✨ The Glycemia Reduction Approaches in Diabetes (GRADE) Cohort
✨ & more!
🚨The November 2025 issue of Diabetes has arrived!
🔗http://diabetesjournals.org/diabetes/issue/74/11
Explore the latest research on #diabetes, including:
✨Sustained Weight Loss w/ LEAP2 and Semaglutide
✨Loss of Insulin-+ Cell Clusters & decrease in islet frequency
✨& more!
🔗http://diabetesjournals.org/diabetes/issue/74/11
Explore the latest research on #diabetes, including:
✨Sustained Weight Loss w/ LEAP2 and Semaglutide
✨Loss of Insulin-+ Cell Clusters & decrease in islet frequency
✨& more!
October 20, 2025 at 7:15 PM
🚨The November 2025 issue of Diabetes has arrived!
🔗http://diabetesjournals.org/diabetes/issue/74/11
Explore the latest research on #diabetes, including:
✨Sustained Weight Loss w/ LEAP2 and Semaglutide
✨Loss of Insulin-+ Cell Clusters & decrease in islet frequency
✨& more!
🔗http://diabetesjournals.org/diabetes/issue/74/11
Explore the latest research on #diabetes, including:
✨Sustained Weight Loss w/ LEAP2 and Semaglutide
✨Loss of Insulin-+ Cell Clusters & decrease in islet frequency
✨& more!
Pediatric primary care providers are likely to screen and monitor for early-stage type 1 diabetes, but multi-component interventions in partnership with endocrinology are needed to address barriers
Read here➡️ http://doi.org/10.2337/dc25-1292
@ADA_Pubs
Read here➡️ http://doi.org/10.2337/dc25-1292
@ADA_Pubs
October 20, 2025 at 5:03 PM
Pediatric primary care providers are likely to screen and monitor for early-stage type 1 diabetes, but multi-component interventions in partnership with endocrinology are needed to address barriers
Read here➡️ http://doi.org/10.2337/dc25-1292
@ADA_Pubs
Read here➡️ http://doi.org/10.2337/dc25-1292
@ADA_Pubs